715 related articles for article (PubMed ID: 19670958)
1. Cost minimization of medicare part D prescription drug plan expenditures.
Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
[TBL] [Abstract][Full Text] [Related]
2. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
3. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
4. Beneficiary price sensitivity in the Medicare prescription drug plan market.
Frakt AB; Pizer SD
Health Econ; 2010 Jan; 19(1):88-100. PubMed ID: 19191252
[TBL] [Abstract][Full Text] [Related]
5. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
[TBL] [Abstract][Full Text] [Related]
6. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states.
Davis MM; Patel MS; Halasyamani LK
J Gen Intern Med; 2007 Feb; 22(2):257-63. PubMed ID: 17356996
[TBL] [Abstract][Full Text] [Related]
7. Part D plan enrollment by uninsured medicare beneficiaries.
Maciejewski ML; Farley JF; Hansen RA; Wei D; Harman JS
Med Care; 2010 Feb; 48(2):183-6. PubMed ID: 20057332
[TBL] [Abstract][Full Text] [Related]
8. Potential opportunity cost of neglecting to annually reassess Medicare Part D standalone prescription drug plan offerings: the price of contentment?
Walberg MP; Patel RA
J Am Pharm Assoc (2003); 2009; 49(6):777-82. PubMed ID: 19926558
[TBL] [Abstract][Full Text] [Related]
9. Promoting access and reducing expected out-of-pocket prescription drug costs for vulnerable Medicare beneficiaries: a pharmacist-directed model.
Cutler TW; Stebbins MR; Smith AR; Patel RA; Lipton HL
Med Care; 2011 Apr; 49(4):343-7. PubMed ID: 21407030
[TBL] [Abstract][Full Text] [Related]
10. It pays to compare: assisting Medicare Part D beneficiaries with enrollment yields out-of-pocket cost savings.
Geonnotti KL; Upchurch G; Roth MT; Weinberger M
J Am Geriatr Soc; 2011 May; 59(5):953-5. PubMed ID: 21568975
[No Abstract] [Full Text] [Related]
11. Should Medicare adopt the Veterans Health Administration formulary?
Frakt AB; Pizer SD; Feldman R
Health Econ; 2012 May; 21(5):485-95. PubMed ID: 21506191
[TBL] [Abstract][Full Text] [Related]
12. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
Polinski JM; Mohr PE; Johnson L
Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
[TBL] [Abstract][Full Text] [Related]
13. Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008.
Walberg MP; Patel RA; Amaral MM
J Med Econ; 2008; 11(4):625-37. PubMed ID: 19450072
[TBL] [Abstract][Full Text] [Related]
14. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
Thomas CP; Sussman J; ;
Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
[TBL] [Abstract][Full Text] [Related]
15. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
LaVange LM; Silverman HA
Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
[TBL] [Abstract][Full Text] [Related]
16. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
17. Medicare Part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2009.
Stubbings J; DePue RJ
Am J Manag Care; 2009 Sep; 15(9):645-9. PubMed ID: 19747029
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
De Natale ML
Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
[TBL] [Abstract][Full Text] [Related]
19. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
Cheng LI; Rascati KL
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
[TBL] [Abstract][Full Text] [Related]
20. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]